Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

TADAWUL:4015 Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,920	10,654	8,050	-	-	-
Market Cap Growth	-9.93%	32.35%	-	-	-	-
Enterprise Value	10,740	10,534	7,954	-	-	-
Last Close Price	156.00	149.08	110.34	-	-	-
PE Ratio	24.43	29.88	27.53	-	-	-
Forward PE	21.90	25.61	25.41	-	-	-
PS Ratio	7.50	8.08	7.31	-	-	-
PB Ratio	6.49	7.15	5.73	-	-	-
P/TBV Ratio	6.55	7.20	5.79	-	-	-
P/FCF Ratio	36.18	51.60	32.10	-	-	-
P/OCF Ratio	30.45	40.46	27.20	-	-	-
PEG Ratio	1.56	1.60	1.01	-	-	-
EV/Sales Ratio	7.38	7.99	7.23	-	-	-
EV/EBITDA Ratio	20.59	24.82	23.28	-	-	-
EV/EBIT Ratio	22.33	27.16	25.19	-	-	-
EV/FCF Ratio	35.58	51.02	31.72	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.08
Debt / EBITDA Ratio	0.01	0.00	0.01	0.01	0.01	0.34
Debt / FCF Ratio	0.01	0.01	0.01	0.02	0.02	0.86
Asset Turnover	-	0.77	0.72	0.65	0.50	0.58
Inventory Turnover	-	1.98	2.18	2.44	1.97	2.99
Quick Ratio	-	3.65	3.58	4.16	3.90	2.90
Current Ratio	-	5.10	5.04	5.42	5.06	3.54
Return on Equity (ROE)	-	24.63%	22.32%	14.00%	14.16%	18.40%
Return on Assets (ROA)	-	14.15%	12.89%	10.67%	7.93%	10.79%
Return on Capital (ROIC)	18.63%	16.72%	15.04%	12.36%	9.25%	12.59%
Return on Capital Employed (ROCE)	-	24.70%	21.40%	18.90%	14.40%	19.10%
Earnings Yield	4.10%	3.35%	3.63%	-	-	-
FCF Yield	2.76%	1.94%	3.12%	-	-	-
Dividend Yield	1.96%	2.05%	2.27%	-	-	-
Payout Ratio	48.51%	60.87%	23.94%	86.85%	66.40%	43.83%
Buyback Yield / Dilution	-0.12%	-	-	-600.00%	-	-
Total Shareholder Return	1.88%	2.05%	2.27%	-600.00%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.